Match tier
Listed
Presence
Current · Arkansas
Last published
2025
Sources
OpenAlex · ORCID
Refreshed
2026-10-08
H
Henrique Rodrigues
Role not yet determined Is this you? Add your title
Also affiliated: Universidade Federal de Minas Gerais (2011–2015); University of California San Diego (2014–2015)
4 h-index
12 pubs
221 cited
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Henrique Rodrigues' research focuses on the molecular mechanisms underlying cancer radioresistance. His work has identified the RAS-RAF-miR-296-3p signaling axis as a key regulator that increases Rad18 expression, thereby augmenting resistance to radiation therapy in pancreatic and thyroid cancers. Rodrigues has published 26 works with 254 citations and an h-index of 5. His recent research has involved collaborations with Adam R. Wolfe, Lokesh Akana, Oscar Zuniga, and Stetson Van Matre, all at the University of Arkansas for Medical Sciences, with whom he shares multiple publications. His recent activity indicates ongoing engagement in research.
Metrics
- h-index: 4
- Publications: 12
- Citations: 221
Selected Publications
-
Abstract A033: Targeting SETD2 in Combination with Radiotherapy in Rectal Cancer (2025)
-
SETD2 Loss Predicts Response to Chemoradiotherapy in Rectal Cancer: Clinical Outcomes and Preclinical Validation in Orthotopic Models (2025)
-
Enhancing Rectal Cancer Radiosensitivity and Gut Protection through Methionine Restriction (2025)
-
Abstract A011: Enhanced Radiosensitivity of Pancreatic Cancer Achieved through Inhibition of Cyclin-Dependent Kinase 1 (2024)
-
RAS-RAF-miR-296-3p signaling axis increases Rad18 expression to augment radioresistance in pancreatic and thyroid cancers (2024)
-
Abstract A006: Targeting SETD2 in combination with radiotherapy in rectal cancer (2024)
-
Targeting Tri-Methyl-Histone H3 (Lys27) in Rectal Cancer: A Novel Strategy to Enhance Radiosensitivity and Predict Response to Neoadjuvant Therapy (2023)
-
Abstract 2839: Methionine restriction radiosensitizes KRAS mutant rectal cancer (2023)
Collaboration Network
Top Collaborators
Adam R. Wolfe
University of Arkansas for Medical Sciences
8 shared publications
In database
- RAS-RAF-miR-296-3p signaling axis increases Rad18 expression to augment radioresistance in pancreatic and thyroid cancers
- Abstract 2839: Methionine restriction radiosensitizes KRAS mutant rectal cancer
- Targeting Tri-Methyl-Histone H3 (Lys27) in Rectal Cancer: A Novel Strategy to Enhance Radiosensitivity and Predict Response to Neoadjuvant Therapy
- Abstract A006: Targeting SETD2 in combination with radiotherapy in rectal cancer
- Abstract A011: Enhanced Radiosensitivity of Pancreatic Cancer Achieved through Inhibition of Cyclin-Dependent Kinase 1
Showing 5 of 8 shared publications
Lokesh Akana
University of Arkansas for Medical Sciences
6 shared publications
In database
- Targeting Tri-Methyl-Histone H3 (Lys27) in Rectal Cancer: A Novel Strategy to Enhance Radiosensitivity and Predict Response to Neoadjuvant Therapy
- Abstract A006: Targeting SETD2 in combination with radiotherapy in rectal cancer
- Abstract A011: Enhanced Radiosensitivity of Pancreatic Cancer Achieved through Inhibition of Cyclin-Dependent Kinase 1
- Enhancing Rectal Cancer Radiosensitivity and Gut Protection through Methionine Restriction
- SETD2 Loss Predicts Response to Chemoradiotherapy in Rectal Cancer: Clinical Outcomes and Preclinical Validation in Orthotopic Models
Showing 5 of 6 shared publications
Oscar Zuniga
University of Arkansas for Medical Sciences
4 shared publications
In database
- RAS-RAF-miR-296-3p signaling axis increases Rad18 expression to augment radioresistance in pancreatic and thyroid cancers
- Abstract 2839: Methionine restriction radiosensitizes KRAS mutant rectal cancer
- Abstract A006: Targeting SETD2 in combination with radiotherapy in rectal cancer
- Enhancing Rectal Cancer Radiosensitivity and Gut Protection through Methionine Restriction
Saaimatul Huq
University of Arkansas for Medical Sciences
3 shared publications
In database
- Abstract A011: Enhanced Radiosensitivity of Pancreatic Cancer Achieved through Inhibition of Cyclin-Dependent Kinase 1
- Enhancing Rectal Cancer Radiosensitivity and Gut Protection through Methionine Restriction
- Abstract A033: Targeting SETD2 in Combination with Radiotherapy in Rectal Cancer
Sarita Garg
University of Arkansas for Medical Sciences
2 shared publications
In database
- Abstract 2839: Methionine restriction radiosensitizes KRAS mutant rectal cancer
- Enhancing Rectal Cancer Radiosensitivity and Gut Protection through Methionine Restriction
Stetson Van Matre
University of Arkansas for Medical Sciences
2 shared publications
In database
- Abstract 2839: Methionine restriction radiosensitizes KRAS mutant rectal cancer
- Abstract A011: Enhanced Radiosensitivity of Pancreatic Cancer Achieved through Inhibition of Cyclin-Dependent Kinase 1
Nükhet Aykin‐Burns
University of Arkansas for Medical Sciences
2 shared publications
In database
- Abstract 2839: Methionine restriction radiosensitizes KRAS mutant rectal cancer
- Enhancing Rectal Cancer Radiosensitivity and Gut Protection through Methionine Restriction
Isabelle R. Miousse
University of Arkansas for Medical Sciences
2 shared publications
In database
- Abstract 2839: Methionine restriction radiosensitizes KRAS mutant rectal cancer
- Enhancing Rectal Cancer Radiosensitivity and Gut Protection through Methionine Restriction
Robin Eluvathingal
University of Arkansas for Medical Sciences
1 shared publication
In database
- Abstract 2839: Methionine restriction radiosensitizes KRAS mutant rectal cancer
A.Z. Kesaria
University of Arkansas for Medical Sciences (US)
1 shared publication
- Targeting Tri-Methyl-Histone H3 (Lys27) in Rectal Cancer: A Novel Strategy to Enhance Radiosensitivity and Predict Response to Neoadjuvant Therapy
Eric U. Yee
University of Arkansas for Medical Sciences
1 shared publication
In database
- Targeting Tri-Methyl-Histone H3 (Lys27) in Rectal Cancer: A Novel Strategy to Enhance Radiosensitivity and Predict Response to Neoadjuvant Therapy
Haihua Feng
City of Hope (US)
1 shared publication
- RAS-RAF-miR-296-3p signaling axis increases Rad18 expression to augment radioresistance in pancreatic and thyroid cancers
Daniel E. Eldridge
Winthrop Rockefeller Foundation (US)
1 shared publication
- RAS-RAF-miR-296-3p signaling axis increases Rad18 expression to augment radioresistance in pancreatic and thyroid cancers
Linlin Yang
City of Hope (US)
1 shared publication
- RAS-RAF-miR-296-3p signaling axis increases Rad18 expression to augment radioresistance in pancreatic and thyroid cancers
Changxian Shen
City of Hope (US)
1 shared publication
- RAS-RAF-miR-296-3p signaling axis increases Rad18 expression to augment radioresistance in pancreatic and thyroid cancers
Similar Researchers
Based on overlapping research topics
Ponmari Guruvaiya
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Receptor Mechanisms and Signaling
Pancreatic and Hepatic Oncology Research
Luke Enemark
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Receptor Mechanisms and Signaling
Medical Research
Brandy Ree
Arkansas Colleges of Health Education
Cancer-related molecular mechanisms research
Receptor Mechanisms and Signaling
Medical Research
Ana Clara P. Azevedo‐Pouly
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Receptor Mechanisms and Signaling
Pancreatic and Hepatic Oncology Research
Trent R. Percy
Arkansas Colleges of Health Education
Cancer-related molecular mechanisms research
Receptor Mechanisms and Signaling
Gene expression and cancer classification
Y. Rahmatallah
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Medical Research
Gene expression and cancer classification